Littleton, MA (July 21, 2020) — CIVCO Radiotherapy and Mevion Medical Systems are pleased to announce that Universal Couchtop™ is now validated and available on MEVION S250™ Series Proton Therapy Systems. The Universal Couchtop allows the use of CIVCO’s full line of ProtonSeries™ products, including the ProForm™ head & neck immobilization solution.

The ProForm extension accepts a full range of thermoplastic mask options designed to meet the unique requirements of proton therapy. ProForm also features geometry that allows for direct access to effectively treat CNS patients with a large homogeneous treatment area. Utilizing the Universal Couchtop allows dosimetric consistency with CT SIM, photon, and proton treatment compatible models, improving clinic workflow.

“We are thrilled to partner with Mevion Medical Systems to offer CIVCO’s Universal Couchtop to their proton clinics around the world. Proton therapy is one of the most advanced forms of radiotherapy in the fight against cancer and this validation brings one of the most modern and comprehensive couchtop solutions for enabling those advanced treatments,” said John Steffen, CIVCO’s Senior Director of Product Management.

“We are very excited to add CIVCO to the lineup of Mevion’s customizable immobilization and positioning solutions on our open-platform proton therapy systems,” said Ying Xiong, vice president of product management at Mevion Medical Systems.

About Mevion Medical Systems
Mevion Medical Systems, Inc. is the leading provider of compact
proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China.